Adis International Ltd. Part of Springer Science+Business Media, Trials
Planning
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
06 Feb 2017: According to a Chondrial Therapeutics media release, company is planning to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) and after acceptance of the IND, company will initiate this trial.
Thursday, February 16, 2017
Subscribe to:
Posts (Atom)
